.svg){kind=small}
Dec-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Jumbodose has shown varied performance across different categories and states, with notable fluctuations in its rankings. In the state of New York, the brand's presence in the Tincture & Sublingual category experienced a downward trend over the last few months of 2025. Starting in September, Jumbodose ranked 10th, but by December, it had fallen out of the top 30. This decline indicates a potential challenge in maintaining market share in this category, as the brand's sales also decreased significantly during this period. The absence of a ranking in December could suggest increased competition or a shift in consumer preferences.
While New York's performance highlights some challenges for Jumbodose, it's important to consider the broader market dynamics that might be influencing these changes. The brand's drop in ranking from 10th to 13th over three months suggests that while it remains a recognized player, there is a need to address the factors contributing to this decline. The reduction in sales could be indicative of a broader trend affecting the tincture and sublingual market, or it could point to specific issues within Jumbodose's product offerings or marketing strategies. Understanding these underlying causes is crucial for Jumbodose to strategize effectively and regain its standing in future rankings.
Competitive Landscape
In the competitive landscape of New York's Tincture & Sublingual category, Jumbodose has experienced a notable decline in both rank and sales over the last few months of 2025. Starting from a rank of 10th in September, Jumbodose fell to 11th in October, 13th in November, and was absent from the top 20 by December. This downward trend in ranking is mirrored by a significant decrease in sales, from a high in September to a much lower figure by November. In contrast, Chime & Chill has maintained a relatively stable position, consistently ranking around 12th and even surpassing Jumbodose in November. Additionally, Canna Dots emerged in December, debuting at 12th, suggesting a potential new competitor in the market. These shifts indicate a challenging environment for Jumbodose, highlighting the need for strategic adjustments to regain its competitive edge in this dynamic market.
Notable Products
In December 2025, the CBN/THC 5:1 Doze Tincture (1500mg CBN, 300mg THC, 30ml) maintained its position as the top-performing product for Jumbodose, despite a decrease in sales to 42 units. The Rosin Drops Hash Tincture (300mg THC, 30ml) followed closely in second place, showing consistent performance from the previous month. The CBG/THC 5:1 Focus Tincture (1500mg CBG, 300mg THC, 30ml) climbed to third place, recovering from a dip in November. Meanwhile, the CBD/THC 5:1 Chill Tincture (1500mg CBD, 300mg THC, 30ml) slipped to fourth place, and the Hybrid Mega Tincture (1000mg THC, 30ml, 1oz) continued its decline, dropping to fifth place. Overall, the rankings indicate a stable preference for tinctures with a focus on specific cannabinoid blends.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
